Video Showcase

Canaccord sets $91 target for Lululemon

12/3/2012 7:09:58 PM | Stockhouse Editorial

1086 Reads | 2 Comments

Rate this

clarity
2

clarity : 2
Rate this:

overall quality
2 overall quality : 2
Average quality rating by the Stockhouse community.

credibility
2

credibility : 2
Rate this:

usefulness
2

usefulness : 2
Rate this:

Australian short seller John Hempton has described Lululemon as a gambit of female vanity, but added that the comment was not meant to be sexist.

Lululemon Athletica Inc. (TSX: T.LLL, Stock Forum) (NASDAQ: LULU, Stock Forum) shares were largely unchanged Monday following reports that Canaccord Genuity has initated coverage of the Canadian athletic apparel company with a buy rating and a target of $91.

The stock eased 0.07% to $71.29, leaving Lululemon with a market cap of $7.6 billion, based on 107.3 million shares outstanding. The 52-week range is $80.08 and $44.32.

“We believe LULU is evolving from an athletic brand with its roots in yoga to a lifestyle brand that is marrying form and function,” said Canaccord retail analyst Camilo Lyon. “To that end, the company has had issues in keeping pace with demand. Our supply chain checks suggest capacity in 2013 will expand and as a result, traffic and conversion should improve, resulting in a reacceleration of comparable growth.’’

As noted by Stockhouse in February, 2012, Australian short seller John Hempton has described Lululemon as a gambit on female vanity.

He was quick to point out that in making that comment, he wasn’t being sexist. “It’s just that Lululemon is, after all, a designer and retailer of technical althletic apparel for yoga and other sweaty pursuits,’’ he said. “Not all of its customers are women, but we see few men shopping at the outlets.’’

ABOUT THE AUTHOR

Stockhouse Editorial

Stockhouse Conflict and Disclosure Policy:

Stockhouse publishing Ltd., owners and operators of Stockhouse.com, has established the following rules to ensure that there is no appearance of impropriety on the part of any Stockhouse Editorial writers ("Writers"). The content of Stockhouse Editorial articles (the "Articles") are the opinion of the Writer and any reliance on the content of these articles is at your sole risk. Our Writers are not registered investment advisors. You should not make any kind of investment decision in relation to Articles or stocks discussed in them without obtaining advice from a registered investment advisor.

Facts relied upon by our Writers are generally provided by the subject companies or gathered by our Writers from other public and/or private sources. These facts may be in error and if so, the opinions of our Writers may be materially different.

Writers may own, buy, or sell shares in public companies mentioned in their Articles, but in the Article they must prominently state their ownership position. Thus, a conflict may exist. Writers are not permitted to write Articles that attempt to benefit persons connected to the Writer, such as family or friends, except where disclosure is made in the same way as if the Writer him/herself owns stock.

Writers cannot solicit, accept, or agree to receive anything of value given or paid with the intent of influencing their Articles.

Stockhouse notifies each Writer about these rules, and we rely on the integrity of our Writers to ensure that our rules are followed.